Effects of low-dose atorvastatin on vascular responses in patients undergoing percutaneous coronary intervention.

被引：0
|
作者：
Bae, JH
Park, KR
Kim, KY
Synn, YC
机构：
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 94卷 / 6A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：194E / 194E
页数：1
相关论文
共 50 条
  • [41] Low-Dose Prasugrel Has Prognostic Superiority to Clopidogrel in High-Bleeding Risk Patients Undergoing Contemporary Percutaneous Coronary Intervention
    Abe, Takuro
    Jujo, Kentaro
    Hata, Takehiro
    Kamishima, Kazuho
    Koganei, Hiroshi
    Sakamoto, Tomohiro
    Yamaguchi, Junichi
    Hagiwara, Nobuhisa
    CIRCULATION, 2020, 142
  • [42] Predictors of no-reflow in patients undergoing primary percutaneous coronary intervention. Thrombus aspiration was protective
    Hassan, Ayman K. M.
    Mohamed, Hamdy Shams Eddin
    Mohamed, Ahmed Mahdy
    Ahmed, Tarek A. N.
    Kishk, Yehia Taha
    EGYPTIAN HEART JOURNAL, 2018, 70 (04): : 421 - 426
  • [43] Temporal Trends in Incidence of Malignancy in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Voudris, Konstantinos V.
    Vidovich, Mladen I.
    CIRCULATION, 2016, 134
  • [44] Vascular injury and response of inflammatory markers after percutaneous coronary intervention.
    Asano, M.
    Kasuga, T.
    Tanabe, Y.
    Fukuda, A.
    Abe, N.
    Ogawa, M.
    Shiobara, H.
    Fujinawa, M.
    Okubo, T.
    Okubo, S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (08): : 71F - 72F
  • [45] Cangrelor Versus Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention. Results of the CHAMPION PCI Study
    Preobrazhensky, D., V
    KARDIOLOGIYA, 2010, 50 (07) : 63 - 64
  • [46] Insights From Endogenous Thrombin Generation In Patients Undergoing Percutaneous Coronary Intervention. A Cohort Study
    Schiele, Francois
    Raccadot, Evelyne
    Meneveau, Nicolas
    Descotes-Genon, Vincent
    Chopard, Romain
    Seronde, Marie-France
    Bassand, Jean-Pierre
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (6A): : 187D - 187D
  • [47] Comparison of Coronary Artery Disease among Rheumatoid Arthritis Patients and Matched Controls Undergoing Percutaneous Coronary Intervention.
    Desai, Sonali P.
    Januzzi, James L.
    Pande, Ashvin N.
    Pomerantsev, Eugene V.
    Resnic, Frederic S.
    Fossel, Anne H.
    Chibnik, Lori B.
    Solomon, Daniel H.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (12): : 4002 - 4003
  • [48] Effects of eptifibatide, bivalirudin and clopidogrel on platelet function in patients undergoing percutaneous coronary intervention. Final results of the DEACON study
    Saucedo, JF
    Thorn, B
    Aude, W
    Pacheco, R
    Shuler, S
    Matin, Z
    Gudapati, S
    Garza, L
    CIRCULATION, 2003, 108 (17) : 576 - 576
  • [49] Clinical outcomes associated with the use of bivalirudin for patients with acute coronary syndrome undergoing early percutaneous coronary intervention.
    Barman, N
    Gurm, H
    Bhatt, D
    Lincoff, AM
    Ellis, S
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (6A): : 191E - 191E
  • [50] Low-Dose Spironolactone: Effects on Artery-to-Artery Vein Grafts and Percutaneous Coronary Intervention Sites
    Bacchetta, Matthew D.
    Salemi, Arash
    Milla, Federico
    Hong, Mun K.
    Tio, Fermin
    Zhou, Ying
    Chen, Rong
    Southard, Edward
    Lee, Leonard Y.
    Mack, Charles A.
    Krieger, Karl H.
    Isom, O. Wayne
    Ko, Wilson
    Borer, Jeffrey S.
    Catanzaro, Daniel F.
    AMERICAN JOURNAL OF THERAPEUTICS, 2009, 16 (03) : 204 - 214
12345